Filitra is a brand name for a medication called Vardenafil, which is primarily used to treat erectile dysfunction (ED) in men. It belongs to a class of drugs known as phosphodiesterase type 5 (PDE5) inhibitors. While Filitra dosage is not specifically approved for the treatment of benign prostatic hyperplasia (BPH), it is worth noting that some PDE5 inhibitors, such as Tadalafil (Cialis), have been approved by regulatory authorities for the treatment of both ED and BPH.
Tadalafil, in particular, is known to relax the smooth muscles in the prostate and bladder, which can help relieve urinary symptoms associated with BPH. However, the efficacy of Vardenafil specifically for BPH has not been established, and it is not commonly prescribed for this purpose. If you are experiencing symptoms of BPH, such as frequent urination, weak urine flow, or difficulty in emptying the bladder completely, it is important to consult a healthcare professional. They will be able to evaluate your symptoms, provide an accurate diagnosis, and recommend appropriate treatment options, which may include medications specifically approved for BPH or other interventions.
Call: 876-927-9941–3 .
